US2788651006 - Common Stock

Overall **ECL** gets a fundamental rating of **5** out of 10. We evaluated **ECL** against 84 industry peers in the **Chemicals** industry. **ECL** scores excellent on profitability, but there are some minor concerns on its financial health. **ECL** is valied quite expensively at the moment, while it does show a decent growth rate.

In the past year **ECL** was profitable.

In the past year **ECL** had a positive cash flow from operations.

In the past 5 years **ECL** always reported a positive cash flow from operatings.

The **Return On Assets** of **ECL** (**6.28%**) is better than **77.38%** of its industry peers.

Looking at the **Return On Invested Capital**, with a value of **9.83%**, **ECL** belongs to the top of the industry, outperforming **82.14%** of the companies in the same industry.

The 3 year average ROIC (**8.73%**) for **ECL** is below the current ROIC(**9.83%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6.28% | ||

ROE | 17.06% | ||

ROIC | 9.83% |

ROA(3y)5.57%

ROA(5y)3.5%

ROE(3y)15.93%

ROE(5y)9.24%

ROIC(3y)8.73%

ROIC(5y)9.03%

Looking at the **Profit Margin**, with a value of **8.96%**, **ECL** is in the better half of the industry, outperforming **77.38%** of the companies in the same industry.

With a decent **Operating Margin** value of **13.88%**, **ECL** is doing good in the industry, outperforming **75.00%** of the companies in the same industry.

Looking at the **Gross Margin**, with a value of **40.39%**, **ECL** belongs to the top of the industry, outperforming **82.14%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 13.88% | ||

PM (TTM) | 8.96% | ||

GM | 40.39% |

OM growth 3Y0.52%

OM growth 5Y-1.24%

PM growth 3YN/A

PM growth 5Y-1.67%

GM growth 3Y-1.08%

GM growth 5Y-0.45%

Compared to 1 year ago, **ECL** has more shares outstanding

Compared to 5 years ago, **ECL** has less shares outstanding

The debt/assets ratio for **ECL** has been reduced compared to a year ago.

An Altman-Z score of **4.45** indicates that **ECL** is not in any danger for bankruptcy at the moment.

The Debt to FCF ratio of **ECL** is **5.00**, which is a neutral value as it means it would take **ECL**, **5.00** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.94** indicates that **ECL** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.94 | ||

Debt/FCF | 5 | ||

Altman-Z | 4.45 |

ROIC/WACC1.15

WACC8.55%

A Quick Ratio of **0.95** indicates that **ECL** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.3 | ||

Quick Ratio | 0.95 |

The **Earnings Per Share** has grown by an nice **16.04%** over the past year.

EPS 1Y (TTM)16.04%

EPS 3Y7.79%

EPS 5Y-0.15%

EPS growth Q2Q22.05%

Revenue 1Y (TTM)7.98%

Revenue growth 3Y9.12%

Revenue growth 5Y0.87%

Revenue growth Q2Q7.28%

EPS Next Y23.75%

EPS Next 2Y19.1%

EPS Next 3Y17.05%

EPS Next 5Y14.59%

Revenue Next Year5.06%

Revenue Next 2Y5.15%

Revenue Next 3Y5.22%

Revenue Next 5Y5.51%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Based on the **Price/Earnings** ratio of **41.87**, the valuation of **ECL** can be described as expensive.

The average S&P500 **Price/Earnings** ratio is at **24.76**. **ECL** is valued rather expensively when compared to this.

A **Price/Forward Earnings** ratio of **33.84** indicates a quite expensive valuation of **ECL**.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 41.87 | ||

Fwd PE | 33.84 |

Based on the **Enterprise Value to EBITDA** ratio, **ECL** is valued a bit more expensive than 75.00% of the companies in the same industry.

The rest of the industry has a similar **Price/Free Cash Flow** ratio as **ECL**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 38.1 | ||

EV/EBITDA | 22.83 |

The **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

The decent profitability rating of **ECL** may justify a higher PE ratio.

A more expensive valuation may be justified as **ECL**'s earnings are expected to grow with **17.05%** in the coming years.

PEG (NY)1.76

PEG (5Y)N/A

EPS Next 2Y19.1%

EPS Next 3Y17.05%

Compared to an average industry **Dividend Yield** of **3.31**, **ECL** has a dividend in line with its industry peers.

With a **Dividend Yield** of **1.04**, **ECL** pays less dividend than the S&P500 average, which is at **2.44**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.04% |

The dividend of **ECL** has a limited annual growth rate of **4.71%**.

As **ECL** did not decrease their dividend in the past **5** years, we can say the dividend looks stable.

Dividend Growth(5Y)4.71%

Div Incr Years6

Div Non Decr Years6

The dividend of **ECL** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP44.98%

EPS Next 2Y19.1%

EPS Next 3Y17.05%

**ECOLAB INC**

NYSE:ECL (4/19/2024, 7:04:00 PM)

After market: 218.16 0 (0%)**218.16**

**-1.05 (-0.48%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap62.37B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.04% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 41.87 | ||

Fwd PE | 33.84 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)1.76

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6.28% | ||

ROE | 17.06% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 13.88% | ||

PM (TTM) | 8.96% | ||

GM | 40.39% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.7

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.94 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.3 | ||

Quick Ratio | 0.95 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)16.04%

EPS 3Y7.79%

EPS 5Y

EPS growth Q2Q

EPS Next Y23.75%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)7.98%

Revenue growth 3Y9.12%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y